Benda's Jiangling Plant Receives Production Approval

Benda Pharmaceutical, Inc., a China-based pharmaceutical company producing both Gendicine, [a] gene therapy medicine for the treatment of cancer and traditional Chinese and conventional medicines, announced that its Jiangling plant has received approval from the State Food and Drug Administration (“SFDA”) to reinitiate production of its primary product line.
TradingMarkets